Objectives:The International Prostate Symptoms Score (I-PSS) was designed t
o be self-administered to patients with benign prostatic hyperplasia. This
study tested for a possible mode of administration effect on the I-PSS and
assessed the reliability of the I-PSS over time when modes of administratio
n varied.
Methods: Benign prostatic hyperplasia patients over 50 years of age were re
cruited at 52 Spanish centres. The I-PSS was administered on two occasions
1 month apart. Patients were sequentially classified into groups A-D accord
ing to the mode of administration (S self-administered, I = interview admin
istered) at the two visits (A = S-S, B = S-I, C = I-S, and D I-I). The intr
aclass correlation coefficient was used to assess test-retest reliability,
and multiple regression analysis was used to test the effects of the mode o
f administration and the visit number on I-PSS scores.
Results: 926 patients (mean age 66 years) were evaluated. The mean I-PSSs s
ymptoms score at visit 1 in groups A-D were, respectively, 13.19, 13.57, 12
.06, and 12.29. Multiple regression analysis between-group scores were 0.93
points higher when the I-PSS was self-administered and 1.98 points lower a
t the second visit. The intraclass correlation coefficients were: group A =
0.77, group B = 0.70, group C = 0.67, and group D = 0.76.
Conclusions: Interview administration of the I-PSS results in slightly lowe
r scores. The reliability is higher when the same mode of administration is
used at two recurrent visits. Copyright (C) 2001 S. Karger AG, Basel.